BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19751402)

  • 1. Antibodies determine virulence in dengue.
    Halstead SB
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E48-56. PubMed ID: 19751402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dengue hemorrhagic Fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002.
    Alvarez M; Rodriguez-Roche R; Bernardo L; Vázquez S; Morier L; Gonzalez D; Castro O; Kouri G; Halstead SB; Guzman MG
    Am J Trop Med Hyg; 2006 Dec; 75(6):1113-7. PubMed ID: 17172378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.
    Yeh WT; Chen RF; Wang L; Liu JW; Shaio MF; Yang KD
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):84-90. PubMed ID: 16965355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue hemorrhagic fever with special emphasis on immunopathogenesis.
    Kurane I
    Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):329-40. PubMed ID: 17645944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.
    Endy TP; Nisalak A; Chunsuttitwat S; Vaughn DW; Green S; Ennis FA; Rothman AL; Libraty DH
    J Infect Dis; 2004 Mar; 189(6):990-1000. PubMed ID: 14999601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.
    Lin CF; Lei HY; Shiau AL; Liu CC; Liu HS; Yeh TM; Chen SH; Lin YS
    J Med Virol; 2003 Jan; 69(1):82-90. PubMed ID: 12436482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue in the Dominican Republic: epidemiology for 2004.
    Cabrera-Batista B; Skewes-Ramm R; Fermin CD; Garry RF
    Microsc Res Tech; 2005 Nov; 68(3-4):250-4. PubMed ID: 16276520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies from patients with dengue viral infection mediate cellular cytotoxicity.
    García G; Arango M; Pérez AB; Fonte L; Sierra B; Rodríguez-Roche R; Aguirre E; Fiterre I; Guzmán MG
    J Clin Virol; 2006 Sep; 37(1):53-7. PubMed ID: 16787760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity and immunopathology in dengue virus infections.
    Kurane I; Ennis FE
    Semin Immunol; 1992 Apr; 4(2):121-7. PubMed ID: 1617166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia.
    Porter KR; Beckett CG; Kosasih H; Tan RI; Alisjahbana B; Rudiman PI; Widjaja S; Listiyaningsih E; Ma'Roef CN; McArdle JL; Parwati I; Sudjana P; Jusuf H; Yuwono D; Wuryadi S
    Am J Trop Med Hyg; 2005 Jan; 72(1):60-6. PubMed ID: 15728868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dengue fever and hemorrhagic dengue in infants with a primary infection].
    Martínez E; Guzmán MG; Valdés M; Soler M; Kourí G
    Rev Cubana Med Trop; 1993; 45(2):97-101. PubMed ID: 7984823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue virus infects macrophages and dendritic cells in a mouse model of infection.
    Kyle JL; Beatty PR; Harris E
    J Infect Dis; 2007 Jun; 195(12):1808-17. PubMed ID: 17492597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis in tissues from fatal dengue shock syndrome.
    Limonta D; Capó V; Torres G; Pérez AB; Guzmán MG
    J Clin Virol; 2007 Sep; 40(1):50-4. PubMed ID: 17693133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever.
    Wang WK; Chen HL; Yang CF; Hsieh SC; Juan CC; Chang SM; Yu CC; Lin LH; Huang JH; King CC
    Clin Infect Dis; 2006 Oct; 43(8):1023-30. PubMed ID: 16983615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
    Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP
    J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles.
    Nguyen TH; Lei HY; Nguyen TL; Lin YS; Huang KJ; Le BL; Lin CF; Yeh TM; Do QH; Vu TQ; Chen LC; Huang JH; Lam TM; Liu CC; Halstead SB
    J Infect Dis; 2004 Jan; 189(2):221-32. PubMed ID: 14722886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.
    Kuruvilla JG; Troyer RM; Devi S; Akkina R
    Virology; 2007 Dec; 369(1):143-52. PubMed ID: 17707071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys.
    Kochel TJ; Watts DM; Gozalo AS; Ewing DF; Porter KR; Russell KL
    J Infect Dis; 2005 Mar; 191(6):1000-4. PubMed ID: 15717278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathological mechanisms in dengue and dengue hemorrhagic fever.
    Green S; Rothman A
    Curr Opin Infect Dis; 2006 Oct; 19(5):429-36. PubMed ID: 16940865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine model for dengue virus-induced lethal disease with increased vascular permeability.
    Shresta S; Sharar KL; Prigozhin DM; Beatty PR; Harris E
    J Virol; 2006 Oct; 80(20):10208-17. PubMed ID: 17005698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.